Skip Navigation

Cardiovascular Research 2006 70(3):589-599; doi:10.1016/j.cardiores.2006.02.027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gazzieri, D.
Right arrow Articles by Harrison, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazzieri, D.
Right arrow Articles by Harrison, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide

David Gazzieria, Marcello Trevisania,b, Francesca Tarantinib, Paolo Bechic, Giulio Masottib, Gian Franco Gensinic, Sergio Castellanic, Niccolo' Marchionnib, Pierangelo Geppettia,b,* and Selena Harrisonb

aCenter of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy
bUnit of Geriatric Medicine, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
cUnit of Internal Medicine, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy

* Corresponding author. Department of Critical Care Medicine and Surgery, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. Tel.: +39 055 4271239; fax: +39 055 4271280. Email address: pierangelo.geppetti{at}unifi.it

Objectives Consumption of alcoholic beverages reduces the risk of coronary artery disease (CAD), and epidemiological studies have shown that ethanol per se is protective. However, the mechanism by which ethanol exerts protection is not fully known. Ethanol can stimulate neuropeptide-containing primary sensory neurons via the activation of transient receptor potential vanilloid 1 (TRPV1). Here, we have studied whether ethanol-mediated TRPV1 activation causes the release of calcitonin gene-related peptide (CGRP) that, via dilatation of coronary arteries and other mechanisms, may protect the heart from CAD.

Methods and results Ethanol caused a marked relaxation of small-sized porcine isolated coronary (0.008–2.37%, w/v) and human isolated gastro-epiploic (0.0008–2.37%, w/v) arteries in vitro, an effect that was abolished by capsaicin-desensitization, the TRPV1 antagonist capsazepine, and the CGRP receptor antagonist, CGRP(8–37). In guinea-pig isolated and perfused hearts, ethanol (0.079–0.79%, w/v) increased baseline coronary flow in a concentration-dependent manner: 0.237% ethanol doubled baseline coronary flow. This effect was also abolished by capsaicin-desensitization, capsazepine, and CGRP(8–37). Finally, the ethanol-induced increase in CGRP release from guinea-pig isolated and perfused hearts and from slices of porcine coronary arteries was abolished by capsaicin-desensitization and by capsazepine. Similar functional and neurochemical results were obtained in all preparations with capsaicin.

Conclusions Ethanol, at low concentrations not dissimilar from those found in blood following low to moderate consumption of alcoholic beverages, releases CGRP within coronary arteries via stimulation of TRPV1 on perivascular sensory nerve terminals. Ethanol-induced release of CGRP may contribute to the reduction in the risk of CAD associated with alcohol consumption by various mechanisms, including the increase in coronary flow and arterial dilatation.

KEYWORDS Ethanol; Transient receptor potential vanilloid 1 (TRPV1); Calcitonin gene-related peptide (CGRP); Coronary vasodilatation; Coronary artery disease (CAD)


Time for primary review 26 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.